Adjunctive Nutraceutical Therapies for COVID-19. Int J Mol Sci 2021 Feb 16;22(4)
Date
03/07/2021Pubmed ID
33669456Pubmed Central ID
PMC7920448DOI
10.3390/ijms22041963Scopus ID
2-s2.0-85100975614 (requires institutional sign-in at Scopus site) 31 CitationsAbstract
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19), is a worldwide pandemic, as declared by the World Health Organization (WHO). It is a respiratory virus that infects people of all ages. Although it may present with mild to no symptoms in most patients, those who are older, immunocompromised, or with multiple comorbidities may present with severe and life-threatening infections. Throughout history, nutraceuticals, such as a variety of phytochemicals from medicinal plants and dietary supplements, have been used as adjunct therapies for many disease conditions, including viral infections. Appropriate use of these adjunct therapies with antiviral proprieties may be beneficial in the treatment and/or prophylaxis of COVID-19. In this review, we provide a comprehensive summary of nutraceuticals, such as vitamins C, D, E, zinc, melatonin, and other phytochemicals and function foods. These nutraceuticals may have potential therapeutic efficacies in fighting the threat of the SARS-CoV-2/COVID-19 pandemic.
Author List
Subedi L, Tchen S, Gaire BP, Hu B, Hu KAuthor
Kurt Hu MD Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsAntiviral Agents
Ascorbic Acid
Dietary Supplements
Functional Food
Humans
Melatonin
Vitamin D
Vitamin E
Vitamins
Zinc
